Pioglitazone and PPAR-γ Modulating Treatment in Hypertensive and Type 2 Diabetic Patients After Ischemic Stroke: A National Cohort Study
Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0979-x
Full Text
Open PDFAbstract
Available in full text
Date
January 7, 2020
Authors
Publisher
Springer Science and Business Media LLC